{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T06:58:53Z","timestamp":1786777133564,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFD1800403"],"award-info":[{"award-number":["2023YFD1800403"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.antiviral.2025.106232","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:43:32Z","timestamp":1752579812000},"page":"106232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pralatrexate effectively inhibits the replication of monkeypox virus in vitro and in vivo"],"prefix":"10.1016","volume":"241","author":[{"given":"Jianshu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaode","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7866-3160","authenticated-orcid":false,"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongzheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0672-948X","authenticated-orcid":false,"given":"Zhiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2025.106232_bib1","article-title":"Human monkeypox virus: an updated review","volume":"101","author":"Adnan","year":"2022","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.antiviral.2025.106232_bib2","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJMoa2412439","article-title":"Tecovirimat for clade I MPXV infection in the Democratic Republic of Congo","volume":"392","author":"Ali","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2025.106232_bib3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/JTO.0b013e31822adb19","article-title":"Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial","volume":"6","author":"Azzoli","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.antiviral.2025.106232_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox-A potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2025.106232_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106004","article-title":"M\u03b2CD inhibits SFTSV entry by disrupting lipid raft structure of the host cells","volume":"231","author":"Cheng","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2025.106232_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archsurg.1970.01340280030009","article-title":"Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal","volume":"101","author":"Chiu","year":"1970","journal-title":"Arch. Surg."},{"key":"10.1016\/j.antiviral.2025.106232_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01825-16","article-title":"CD8+ T cells and macrophages regulate pathogenesis in a mouse model of Middle East respiratory syndrome","volume":"91","author":"Coleman","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2025.106232_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2479043","article-title":"Differential replication, pathology, and immune response of clade IIb mpox virus in C57BL\/6 and BALB\/c mice","author":"Duan","year":"2025","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2025.106232_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral tecovirimat for the treatment of smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2025.106232_bib10","author":"Gu"},{"key":"10.1016\/j.antiviral.2025.106232_bib11","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","article-title":"Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice","volume":"179","author":"Gupta","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2025.106232_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56891-0","article-title":"Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis","volume":"9","author":"Hong","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2025.106232_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/v15051128","article-title":"DHFR inhibitors display a pleiotropic anti-viral activity against SARS-CoV-2: insights into the mechanisms of action","volume":"15","author":"Iaconis","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2025.106232_bib14","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1073\/pnas.1120246109","article-title":"Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57\/BL6 mouse model","volume":"109","author":"Jin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2025.106232_bib15","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1128\/JVI.02174-10","article-title":"Establishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high- and low-dose monkeypox virus challenges","volume":"85","author":"Keckler","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2025.106232_bib16","first-page":"593","article-title":"A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo","volume":"46","author":"Ladnyj","year":"1972","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2025.106232_bib17","article-title":"Mpox virus Clade IIb infected Cynomolgus macaques via mimic natural infection routes closely resembled human mpox infection","volume":"13","author":"Li","year":"2024","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2025.106232_bib18","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","article-title":"A tale of two clades: monkeypox viruses","volume":"86","author":"Likos","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2025.106232_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116070","article-title":"Mahuang Xixin Fuzi decoction protects the BALB\/c-nude mice infected with influenza A virus by reducing inflammatory cytokines storm and weakly regulating SIgA immune response","volume":"304","author":"Liu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.antiviral.2025.106232_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","article-title":"A Pox\u2010like disease in cynomolgus monkeys","volume":"46","author":"Magnus","year":"2009","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.antiviral.2025.106232_bib21","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1158\/1078-0432.CCR-10-1214","article-title":"Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary","volume":"16","author":"Malik","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.antiviral.2025.106232_bib22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/s41467-025-56800-2","article-title":"Strong and early monkeypox virus-specific immunity associated with mild disease after intradermal clade-IIb-infection in CAST\/EiJ-mice","volume":"16","author":"Meyer Zu Natrup","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2025.106232_bib23","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1080\/10428194.2017.1306642","article-title":"Pralatrexate: a comprehensive update on pharmacology, clinical activity and strategies to optimize use","volume":"58","author":"O'Connor","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.antiviral.2025.106232_bib24","first-page":"1027","article-title":"Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention","volume":"33","author":"Petersen","year":"2019","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.antiviral.2025.106232_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2015.05.017","article-title":"Hepatitis B virus induces RNR-R2 expression via DNA damage response activation","volume":"63","author":"Ricardo-Lax","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2025.106232_bib26","article-title":"In vitro and in vivo models for monkeypox","volume":"26","author":"Rosa","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.antiviral.2025.106232_bib27","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/s41467-025-57219-5","article-title":"Structural basis of Nipah virus RNA synthesis","volume":"16","author":"Sala","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2025.106232_bib28","series-title":"Medicinal Chemistry of Chemotherapeutic Agents","first-page":"499","article-title":"Chapter 15 - synthetic cytotoxic drugs as cancer chemotherapeutic agents","author":"Singh","year":"2023"},{"key":"10.1016\/j.antiviral.2025.106232_bib29","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.3201\/eid2912.231146","article-title":"Tecovirimat resistance in Mpox patients, United States, 2022-2023","volume":"29","author":"Smith","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2025.106232_bib30","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1038\/s41598-025-88725-7","article-title":"Establishment of an animal model for monkeypox virus infection in dormice","volume":"15","author":"Song","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2025.106232_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/v14091894","article-title":"Monkeypox, a literature review: what is new and where does this concerning virus come from?","volume":"14","author":"Tiecco","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2025.106232_bib32","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2024.21091","article-title":"Mpox clinical presentation, diagnostic approaches, and treatment strategies: a review","volume":"332","author":"Titanji","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2025.106232_bib33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41564-025-01936-6","article-title":"Structural insights into tecovirimat antiviral activity and poxvirus resistance","volume":"10","author":"Vernuccio","year":"2025","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.antiviral.2025.106232_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","article-title":"AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2025.106232_bib35","article-title":"Discovery of novel inhibitors of dengue viral RNA-dependent RNA polymerase by molecular docking, in vitro assay, DFT, and MD simulations","author":"Wei","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.antiviral.2025.106232_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105787","article-title":"Pralatrexate inhibited the replication of varicella zoster virus and vesicular stomatitis virus: an old dog with new tricks","volume":"221","author":"Wu","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2025.106232_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155526","article-title":"Folate metabolism negatively regulates OAS-mediated antiviral innate immunity via ADAR3\/endogenous dsRNA pathway","volume":"143","author":"Wu","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.antiviral.2025.106232_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009587","article-title":"Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome","volume":"17","author":"Xu","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2025.106232_bib39","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2025.106232_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1179\/1351000215Y.0000000041","article-title":"The effects of lycopene on intestinal injury due to methotrexate in rats","volume":"21","author":"Yucel","year":"2016","journal-title":"Redox Rep."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354225001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354225001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:51:24Z","timestamp":1779616284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354225001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"alternative-id":["S0166354225001585"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2025.106232","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pralatrexate effectively inhibits the replication of monkeypox virus in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2025.106232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106232"}}